Management of vitreous floaters: an international survey the European Vitreo Retinal Society Floaters study report

Autor: Zeydanli, E. O., Parolini, B., Ozdek, S., Bopp, S., Adelman, R. A., Kuhn, F., Gini, G., Sallam, A. B., Aksakal, N., Ellabban, A. A., Chhablani, J., Fiser, I., Brazda, F., Bedrich, P., Kanovsky, R., Koch, P., Unsal, E., Matonti, F., Aristodemou, P., Boon, C. J. F., Szijarto, Z., Estacy, G., Kusserow, C., Turco, I., Badat, I., Brix, A., Lucke, K., Schuler, A., Ducournau, D., Veith, M., Primavera, V., Noci, N. D., Hamon, F., Uy, R., Soyeur, R., Fourmaux, E., Demosthenos, C., Becquet, F., Berrod, J. -P., Hubert, I., Rusnak, S., Neves, P., Martins, D., Tosi, G. M., Glacet-Bernard, A., Mochi, B., Aroca, P. R., Lafontaine, P. -O., Lytvynchuk, L., Saeed, M., Gunda, M., Gremillion, C.
Přispěvatelé: Ophthalmology, Amsterdam Neuroscience - Complex Trait Genetics
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Eye, 34(5), 825-834. NATURE PUBLISHING GROUP
Eye (London, England), 34(5), 825-834. Nature Publishing Group
Eye (Lond)
ISSN: 0950-222X
Popis: Upon completion of this activity, participants will be able to: In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Springer Nature. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 1.0 Release date: Expiration date: 19 April 2020 Post-test link: https://medscape.org/eye/posttest924758 Sobha Sivaprasad, MD, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Allergan, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Heidelberg Pharma GmbH; Optos; Roche. Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Bayer AG; Novartis Pharmaceuticals Corporation; Optos. Received grants for clinical research from: Allergan, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Optos. EOZ, MD, has disclosed no relevant financial relationships. BP, MD, has disclosed no relevant financial relationships. SO, MD, has disclosed no relevant financial relationships. SB, MD, has disclosed the following relevant financial relationships: served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Bayer AG; Novartis Pharmaceuticals Corporation. RAA, MD, MPH, has disclosed no relevant financial relationships. FK, MD, has disclosed no relevant financial relationships. GG, MD, has disclosed no relevant financial relationships. AS, MD, has disclosed no relevant financial relationships. NA, MD, has disclosed no relevant financial relationships. Laurie Barclay, MD, Freelance writer and reviewer, Medscape, LLC, and has disclosed no relevant financial relationships. To evaluate the efficacy and safety of pars plana vitrectomy for symptomatic floaters. Forty-eight vitreoretinal surgeons from 16 countries provided information on 581 eyes who underwent vitrectomy for floaters in this retrospective survey study conducted by European VitreoRetinal Society. Percentage symptomatic improvement, incidence of retinal tears/detachment and post-vitrectomy cataract surgery, and the factors associated with satisfaction and complications were investigated. Ninety-two percent were satisfied with the results, with 86.3% reporting complete resolution of daily-life symptoms. Overall satisfaction was lower in patients with smaller vitreous opacities at presentation (OR:0.4). Iatrogenic retinal breaks occurred in 29 eyes (5%). Core vitrectomy and cut rates of 1500–4000 or >4000 cuts/min were associated with lower risk of retinal breaks than complete vitrectomy (OR:0.05) and cut rates 1500 cuts/min are favoured. Proper patient selection and informed consent are the most important aspects of surgery.
Databáze: OpenAIRE
Externí odkaz: